Electrocardiography

Cardiac Insight Comments on Medicare Administrative Contractor Novitas Rate Publication

Retrieved on: 
Monday, February 1, 2021
Medical devices, Health, Technology, Software, General Health, Cardiology, Branches of biology, Medicine, Cardiac electrophysiology, Clinical medicine, Electrodiagnosis, Electrocardiography, Electrophysiology

Cardiac Insight , Inc. a healthcare innovator specializing in wearable cardiac sensors and proven automated electrocardiogram (ECG) analysis that delivers highly differentiated benefits to healthcare providers and patients, commented on the recent reimbursement rates published by Medicare Administrative Contractor (MAC) Novitas Solutions (Novitas) for CPT codes 93241, 93243, 93245, and 93247.

Key Points: 
  • Cardiac Insight , Inc. a healthcare innovator specializing in wearable cardiac sensors and proven automated electrocardiogram (ECG) analysis that delivers highly differentiated benefits to healthcare providers and patients, commented on the recent reimbursement rates published by Medicare Administrative Contractor (MAC) Novitas Solutions (Novitas) for CPT codes 93241, 93243, 93245, and 93247.
  • Novitas provides administrative and claims processing services for state and federal health care programs such as Medicare and Medicaid and is owned by GuideWell.
  • This untenable decision significantly sets back patient care as it will limit access to extended ECG testing for patients and physicians nationwide, said Brad Harlow, CEO of Cardiac Insight.
  • ABOUT CARDIAC INSIGHT, INC: Cardiac Insight, Inc. ( www.cardiacinsightinc.com ) is a leading U.S. digital healthcare innovation company specializing in the development of medical-grade, body-worn ECG sensor technology and automated cardiac analysis solutions through its proprietary algorithms and software platforms.

Worldwide Wireless ECG Devices Industry to 2025 - Declining Cost of Wireless Technologies is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, February 1, 2021
Medical devices, Health, Mobile, Wireless, Technology, Cardiology, Medicine, Clinical medicine, Branches of biology, Cardiac electrophysiology, Electrodiagnosis, Medical monitoring, Heart diseases, Electrocardiography, Electrophysiology, Cardiac monitoring, Monitoring, Cardiovascular disease

Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Key Points: 
  • Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.
  • Increasing awareness regarding early detection and management of cardiovascular diseases is augmenting the demand for continuous cardiovascular ECG monitoring devices.
  • The development of commercially advanced devices, with enabled Bluetooth sensor technology and mobile app technology, is anticipated to drive the popularity of continuous cardiovascular ECG monitoring systems.
  • The United States holds the largest market share in the North American wireless ECG devices market, and it is expected to register a high growth rate over the forecast period.

AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG

Retrieved on: 
Monday, February 1, 2021
Branches of biology, Medicine, Medical technology, Cardiac electrophysiology, Cardiac arrhythmia, Medical devices, Alivecor, Electrocardiography, Cardiac monitoring, Tachycardia, Atrial fibrillation, Wireless ambulatory ECG

MOUNTAIN VIEW, Calif., Feb. 1, 2021 /PRNewswire/ -- AliveCor , the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today launched an expanded range of ECG determinations on its KardiaMobile devices.

Key Points: 
  • MOUNTAIN VIEW, Calif., Feb. 1, 2021 /PRNewswire/ -- AliveCor , the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today launched an expanded range of ECG determinations on its KardiaMobile devices.
  • KardiaMobile devices already detect Atrial Fibrillation, Bradycardia, and Tachycardia, making six total heart conditions these devices can identify.
  • "This is a turning point in remote cardiac monitoringno other personal ECG in the world can offer this range of determinations and this level of accuracy," said Dr. Dave Albert, Chief Medical Officer at AliveCor.
  • AliveCor is a privately-held company headquartered in Mountain View, Calif. "Consumer" or "Personal" ECGs are ECG devices available for direct sale to consumers.

Global Cardiac Monitoring Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, January 29, 2021
Health, Medical devices, Cardiology, Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Electrocardiography, Cardiac monitoring, Monitoring, Heart, Wireless ambulatory ECG

The increase in the incidence of cardiovascular diseases (CVD) necessitates the need for long-term ECG monitoring.

Key Points: 
  • The increase in the incidence of cardiovascular diseases (CVD) necessitates the need for long-term ECG monitoring.
  • There are two different types of ECG monitors available in the market, namely monitoring ECG systems and diagnostic ECG systems.
  • North American holds the leading position in the cardiac monitoring market.
  • Furthermore, continuous advancements in the technology, growing awareness in patients about cardiac monitoring, well-established healthcare infrastructure, and favorable reimbursement policies are expected to boost the cardiac monitoring market in the North America region.

Veteran Cardiology Medtech Executive Tim O'Malley Joins iMedrix Mobile Cardiology as CEO

Retrieved on: 
Friday, January 29, 2021
Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Cardiac monitoring, O'Malley, Electrocardiography, Monitoring

MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ --Tim O'Malley, has joined iMedrixInc.manufacturer of KardioScreen, the world's first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer.

Key Points: 
  • MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ --Tim O'Malley, has joined iMedrixInc.manufacturer of KardioScreen, the world's first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer.
  • Mr. O'Malley joins the firm from EarlySense Inc., where he was their President and Chief Growth Officer.
  • "We are pleased to welcome Tim O'Malley to iMedrix at this important time in our history.
  • "With a truly Mobile ECG Platform, there is the ability to capture diagnostic grade ECGs almost anywhere and by anyone, "said Jadcherla.

Global ECG Telemetry Devices Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 28, 2021
Health, Other Health, Branches of biology, Medicine, Cardiac electrophysiology, Clinical medicine, Electrophysiology, Electrocardiography, Electrodiagnosis, Telemetry

However, ECG telemetry devices are the most effective tools for the detection of arrhythmias.

Key Points: 
  • However, ECG telemetry devices are the most effective tools for the detection of arrhythmias.
  • The cardiovascular diagnostic sector prefers ECG telemetry devices, as they are the easiest and fastest tools for the diagnoses of CVDs.
  • This is ultimately contributing to the growth of the ECG telemetry devices market in the United States.
  • Additionally, investments in healthcare are increasing in the United States, which is ultimately helping the growth of the ECG telemetry devices market.

VivaQuant Introduces Smallest One-Piece Mobile Cardiac Telemetry Device

Retrieved on: 
Thursday, January 28, 2021
Health, Medical devices, Cardiology, Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Medical emergencies, Medical monitoring, Cardiac monitoring, Electrocardiography, Arrhythmia, Heart, Monitoring, Telemetry

VivaQuant , a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, is proud to announce launch of the RX-1 mini.

Key Points: 
  • VivaQuant , a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, is proud to announce launch of the RX-1 mini.
  • The mini is the smallest one-piece mobile cardiac telemetry device on the market, setting a new standard for patient comfort and simplicity of use.
  • This results in lower operating costs and crisp high-clarity ECGs that can enable faster diagnosis for patients with cardiac disease.
  • VivaQuant is a digital health company providing remote cardiac monitoring services under the Rhythm ExpressTM brand.

BioSig PURE EP System Featured in the Editorial of EP Lab Digest

Retrieved on: 
Thursday, January 14, 2021
Medicine, Branches of biology, Clinical medicine, Electrodiagnosis, Cardiac electrophysiology, Electrocardiography, Electrophysiology

BioSig Technologies, Inc. (NASDAQ: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the PURE EP System was featured in the January issue of EP Lab Digest.

Key Points: 
  • BioSig Technologies, Inc. (NASDAQ: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the PURE EP System was featured in the January issue of EP Lab Digest.
  • Dr. Knight highlights how the PURE EP System addresses these current limitations through its novel hardware architecture and its proprietary signal processing software.
  • This is the latest editorial in a series of publications featuring BioSigs PURE EP System in the industry-leading media outlets.
  • PURE EP System was recently highlighted in several physician users interviews, including the December 2020 feature interview with Rafaelle Corbisiero, M.D.

CardioComm Solutions Provides Financial Update

Retrieved on: 
Monday, January 11, 2021
Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Electrodiagnosis, Medical tests, ERT, Electrocardiography

Toronto, Ontario--(Newsfile Corp. - January 10, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is confirming the appointment of a new Chief Financial Officer and completion of a debt to equity settlement.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - January 10, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is confirming the appointment of a new Chief Financial Officer and completion of a debt to equity settlement.
  • CardioComm Solutions, Inc. also confirms the appointment of Ms. Jose Bertrand as the Company's Chief Financial Officer.
  • CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients.
  • FOR FURTHER INFORMATION PLEASE CONTACT:
    This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items.

Biotricity Submitted 510(k) U.S. FDA Filing for Biotres

Retrieved on: 
Tuesday, January 5, 2021
Medicine, Branches of biology, Clinical medicine, Siddiq, Electrocardiography, Forward-looking statement, Human Research Facility Holter Monitor

We are excited to announce the 510(k) FDAsubmissionforBiotresand look forward to building out ourproduct offerings further in 2021, statedWaqaasAl Siddiq, CEO of Biotricity.

Key Points: 
  • We are excited to announce the 510(k) FDAsubmissionforBiotresand look forward to building out ourproduct offerings further in 2021, statedWaqaasAl Siddiq, CEO of Biotricity.
  • We believe thatBiotresaddresses demand fromsome of our existing customers and a need in theholtermarket.
  • TheBiotresis designed with the following key features:
    3 Channel Recording A wearableholterpatch device that can provide continuous 3 channel recording of ECG (heart) data.
  • Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements.